Cargando…
Dietary Mg Supplementation Decreases Oxidative Stress, Inflammation, and Vascular Dysfunction in an Experimental Model of Metabolic Syndrome with Renal Failure
Background: Metabolic syndrome (MetS) and chronic kidney disease (CKD) are commonly associated with cardiovascular disease (CVD) and in these patients Mg concentration is usually decreased. This study evaluated whether a dietary Mg supplementation might attenuate vascular dysfunction through the mod...
Autores principales: | López-Baltanás, Rodrigo, Rodríguez-Ortiz, María E., Díaz-Tocados, Juan M., Martinez-Moreno, Julio M., Membrives, Cristina, Rodelo-Haad, Cristian, Pendón Ruiz de Mier, M. Victoria, Rodríguez, Mariano, Canalejo, Antonio, Almadén, Yolanda, Muñoz-Castañeda, Juan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952257/ https://www.ncbi.nlm.nih.gov/pubmed/36829843 http://dx.doi.org/10.3390/antiox12020283 |
Ejemplares similares
-
The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities
por: Rodelo-Haad, Cristian, et al.
Publicado: (2020) -
The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function
por: Vergara, Noemi, et al.
Publicado: (2022) -
FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019) -
Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
por: Muñoz-Castañeda, Juan Rafael, et al.
Publicado: (2020) -
Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics
por: Arenas, Maria Dolores, et al.
Publicado: (2020)